In a bill chock full of bad policies, the drug pricing provision of the Inflation Reduction Act stands out as particularly troubling. This provision establishes a negotiation process to set a Maximum Fair Price (MFP) on selected drugs for Medicare patients. The MFP for the first 10 drugs were finalized last year (to become effective […]
Author Archives: Wayne Winegarden
Wayne Winegarden, PhD is a Senior Fellow at the Pacific Research Institute and Director of PRI's Center for Medical Economics and Innovation. He wrote this for InsideSources.com.
